Prevention Science

, Volume 15, Issue 3, pp 428–435 | Cite as

Endorsement of Compulsory HIV Vaccination Policy Among Populations at High Risk of HIV Exposure (LA VOICES)

  • Peter A. Newman
  • Sung-Jae Lee
  • Ellen T. Rudy
  • Allison Diamant
  • Naihua Duan
  • Terry Nakazano
  • William E. Cunningham
Article

Abstract

Compulsory vaccination is a frequently implemented policy option for ensuring comprehensive vaccine coverage. Ongoing controversies around human papillomavirus vaccine dissemination, and suboptimal coverage, suggest the value of assessing acceptability of compulsory vaccinations—particularly among likely target populations—in advance of their public availability to support evidence-informed interventions. With the first HIV vaccine to demonstrate partial efficacy in a large-scale clinical trial, we examined individual characteristics and attitudes associated with support for compulsory HIV vaccination policy among a diverse, representative sample of adults attending probable HIV vaccine dissemination venues in a large urban county. Participants were recruited using three-stage probability sampling from likely venues for future HIV vaccine dissemination. We used Audio-CASI to administer a 60-min structured questionnaire. Items included endorsement of compulsory HIV vaccination policy, sociodemographic characteristics, injecting drug use, vaccine attitudes and perceived HIV risk. Among 1,225 participants (mean age = 36.8 years; 55.6 % males, 37.6 % non-English speaking Hispanic, 78.8 % heterosexual, 25.7 % injection drug users), almost half (48.2 %) endorsed a compulsory HIV vaccination policy. Non-English speaking Hispanics compared to whites, participants with less than high school education, higher positive vaccine attitude scores and higher perceived HIV risk were significantly more likely, and people who inject drugs significantly less likely to endorse compulsory HIV vaccination. Public health interventions to promote positive vaccine attitudes and accurate perceptions of HIV risk among vulnerable populations, and strategies tailored for people who inject drugs, may build support for compulsory HIV vaccination policy and promote broad HIV vaccine coverage.

Keywords

HIV vaccines Vaccination Policy Vulnerable populations Attitudes 

References

  1. Bearman, P. (2010). Just-so stories: Vaccines, autism, and the single-bullet disorder. Social Science Quarterly, 73, 112–115.Google Scholar
  2. Centers for Disease Control and Prevention. (1998). Effectiveness of a seventh grade school entry vaccination requirement—statewide and Orange County, Florida, 1997–1998. Morbidity and Mortality Weekly Report, 47, 711–715. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/00054618.htm.
  3. Centers for Disease Control and Prevention. (1999). Ten great public health achievements—United States, 1900–1999. Morbidity and Mortality Weekly Report, 48, 241–243. Retrieved from www.cdc.gov/mmwr/preview/mmwrhtml/00056796.htm.
  4. Centers for Disease Control and Prevention. (2002a). Unrecognized HIV infection, risk behaviors, and perceptions of risk among young black man who have sex with men—six U.S. cities, 1994—1998. Morbidity and Mortality Weekly Report, 51, 733–736. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5133a1.htm.
  5. Centers for Disease Control and Prevention. (2002b). Substance abuse treatment and public health: Working together to benefit injection drug users. Retrieved from www.cdc.gov/idu/facts/workingtogetherFin.pdf.
  6. Centers for Disease Control and Prevention. (2002c). Achievements in public health: Hepatitis B vaccination—United States, 1982–2002. Morbidity and Mortality Weekly Report, 51, 549–552,563. Retrieved from www.cdc.gov/mmwr/preview/mmwrhtml/mm5125a3.htm.
  7. Centers for Disease Control and Prevention. (2006). Hepatitis B vaccination coverage among adults—United States, 2004. Morbidity and Mortality Weekly Report, 55, 509–511. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5518a3.htm.
  8. Centers for Disease Control and Prevention. (2012a). Estimated HIV incidence among adults and adolescents in the United States, 2007–2010. HIV Surveillance Supplemental Report, 17, 14–22. Retrieved from http://www.cdc.gov/hiv/pdf/statistics_hssr_vol_17_no_4.pdf.
  9. Centers for Disease Control and Prevention. (2012b). Teen vaccination coverage: 2011 National Immunization Survey (NIS)—Teen. Retrieved from www.cdc.gov/vaccines/who/teens/vaccination-coverage.html.
  10. Centers for Disease Control and Prevention. (2012c). HIV infection and HIV-associated behaviors among injecting drug users—20 cities, United States, 2009. Morbidity and Mortality Weekly Report, 61, 133–138. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6108a1.htm.
  11. Chesson, H. W., Gift, T. L., Owusu-Edusei, K., Jr., Tao, G., Johnson, A. P., & Kent, C. K. (2011). A brief review of the estimated economic burden of sexually transmitted diseases in the United States: Inflation-adjusted updates of previously published cost studies. Sexually Transmitted Diseases, 38, 889–891.CrossRefPubMedGoogle Scholar
  12. Constantine, N. A., & Jerman, P. (2007). Acceptance of human papillomavirus vaccination among Californian parents of daughters: A representative statewide analysis. Journal of Adolescent Health, 40, 108–115.CrossRefPubMedGoogle Scholar
  13. Derber, C. J., & Shankaran, S. (2012). Health-care worker vaccination for influenza: Strategies and controversies. Current Infectious Disease Reports, 14, 627–632.CrossRefPubMedGoogle Scholar
  14. Ferris, D., Horn, L., & Waller, J. L. (2010). Parental acceptance of a mandatory human papillomavirus (HPV) vaccination program. Journal of the American Board of Family Medicine, 23, 220–229.CrossRefPubMedGoogle Scholar
  15. Fortenberry, J. D., McFarlane, M., & Bleakley, A. (2002). Relationships of stigma and shame to gonorrhea and HIV screening. American Journal of Public Health, 92, 378–381.PubMedCentralCrossRefPubMedGoogle Scholar
  16. Fox, J. (1991). Regression Diagnostics. Newberry Park, CA: Sage.Google Scholar
  17. Gabriel, T., & Grady, D. (2011). In Republican race, a heated battle over the HPV vaccine. Retrieved from www.nytimes.com/2011/09/14/us/politics/republican-candidates-battle-over-hpv-vaccine.html.
  18. Haber, G., Marlow, R. M., & Zimet, G. D. (2007). The HPV vaccine mandate controversy. Journal of Pediatric and Adolescent Gynecology, 20, 325–331.CrossRefPubMedGoogle Scholar
  19. Hall, H. I., Song, R., & Rhodes, P. (2008). Estimation of HIV Incidence in the United States. Journal of the American Medical Association, 300, 520–529.PubMedCentralCrossRefPubMedGoogle Scholar
  20. Kennedy, A. M., Brown, C. J., & Gust, D. A. (2005). Vaccine beliefs of parents who oppose compulsory vaccination. Public Health Reports, 120, 252–258.PubMedCentralPubMedGoogle Scholar
  21. Lechuga, J., Swain, G. R., & Weinhardt, L. S. (2011). The cross-cultural variation of predictors of human papillomavirus vaccination intention. Journal of Women's Health, 20, 225–230.PubMedCentralCrossRefPubMedGoogle Scholar
  22. McGarrigle, C. A., Mercer, C. H., Fenton, K. A., Copas, A. J., Wellings, K., Erens, B., & Johnson, A. M. (2005). Investigating the relationship between HIV testing and risk behavior in Britain: National survey of sexual attitudes and lifestyles 2000. AIDS, 19, 77–84.CrossRefPubMedGoogle Scholar
  23. Metzger, D. S., Koblin, B., Turner, C., Navaline, H., Valenti, F., Holte, S., et al. (2000). Randomized controlled trial of audio computer-assisted self-interviewing: Utility and acceptability in longitudinal studies. American Journal of Epidemiology, 152, 99–106.CrossRefPubMedGoogle Scholar
  24. National Conference of State Legislatures. (2013). HPV vaccine. Retrieved from www.ncsl.org/issues-research/health/hpv-vaccine-state-legislation-and-statues.aspx.
  25. Newman, P. A., & Logie, C. (2010). HIV vaccine acceptability: A systematic review and meta-analysis. AIDS, 24, 1749–1756.CrossRefPubMedGoogle Scholar
  26. Newman, P. A., Duan, N., Rudy, E., Roberts, K. J., & Swendeman, D. (2004). Post-trial HIV vaccine adoption: Concerns, motivators and intentions among persons at risk for HIV. Journal of Acquired Immune Deficiency Syndromes, 37, 1393–1403.CrossRefPubMedGoogle Scholar
  27. Newman, P. A., Duan, N., Lee, S. J., Rudy, E., Seiden, D., Kakinami, L., & Cunningham, W. E. (2006a). HIV vaccine acceptability among communities at risk: The impact of vaccine characteristics. Vaccine, 24, 2094–2101.PubMedCentralCrossRefPubMedGoogle Scholar
  28. Newman, P. A., Duan, N., Roberts, K. J., Seiden, D., Rudy, E. T., Swendeman, D., & Popova, S. (2006b). HIV vaccine trial participation among ethnic minority communities. Journal of Acquired Immune Deficiency Syndromes, 41, 210–217.CrossRefPubMedGoogle Scholar
  29. Newman, P. A., Duan, N., Lee, S. J., Rudy, E. T., Seiden, D., Kakinami, L., & Cunningham, W. E. (2007). Willingness to participate in HIV vaccine trials: The impact of trial attributes. Prevention Medicine, 44, 554–557.CrossRefGoogle Scholar
  30. Nichol, K. L., Mac Donald, R., & Hauge, M. (1996). Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. Journal of General Internal Medicine, 11, 673–677.CrossRefPubMedGoogle Scholar
  31. Ottenberg, A. L., Wu, J. T., Poland, G. A., Jacobson, R. M., Koenig, B. A., & Tilburt, J. C. (2011). Vaccinating health care workers against influenza: The ethical and legal rationale for mandate. American Journal of Public Health, 101, 212–216.PubMedCentralCrossRefPubMedGoogle Scholar
  32. Rebmann, T., Wright, K. S., Anthony, J., Knaup, R. C., & Peters, E. B. (2012). Seasonal influenza vaccine compliance among hospital-based and nonhospital-based healthcare workers. Infection Control and Hospital Epidemiology, 33, 243–249.CrossRefPubMedGoogle Scholar
  33. Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., et al. (2009). Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. New England Journal of Medicine, 361, 2209–2220.CrossRefPubMedGoogle Scholar
  34. Rhodes, T., Singer, M., Bourgois, P., Friedman, S. R., & Strathdee, S. A. (2005). The social structural production of HIV risk among injecting drug users. Social Science & Medince, 61, 1026–1044.CrossRefGoogle Scholar
  35. Roberts, K. J., Newman, P. A., Duan, N., & Rudy, E. T. (2005). HIV vaccine knowledge and beliefs among communities at elevated risk: Conspiracies, questions and confusion. Journal of the National Medical Association, 97, 1662–1671.PubMedCentralPubMedGoogle Scholar
  36. Rosenstock, I. M., Strecher, V. J., & Becker, M. H. (1994). The health belief model and HIV risk behavior change. In R. J. DiClemente & J. L. Peterson (Eds.), Preventing AIDS: Theories and methods of behavioral interventions (pp. 5–22). New York: Plenum Press.CrossRefGoogle Scholar
  37. Salmon, D. A., Moulton, L. H., Omar, S. B., DeHart, M. P., Stokley, S., & Halsey, N. A. (2005). Factors associated with refusal of childhood vaccines among parents of school-aged children: A case–control study. Archives of Pediatrics & Adolescent Medicine, 159, 470–476.CrossRefGoogle Scholar
  38. Shapiro, C. N. (1993). Epidemiology of hepatitis B. Pediatric Infectious Disease Journal, 12, 433–437.CrossRefPubMedGoogle Scholar
  39. Thomas, P. E., Voetsch, A. C., Song, B., Calloway, D., Goode, C., Mundey, L., et al. (2008). HIV risk behaviors and testing history in historically black college and university settings. Public Health Reports, 123, 115–125.PubMedCentralPubMedGoogle Scholar
  40. Workowski, K.A., & Berman, S. (2010). Sexually transmitted diseases treatment guidelines, 2010. Recommendations and Reports, 59, 1–110. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5912a1.htm?s_cid=rr5912a1_e.

Copyright information

© Society for Prevention Research 2014

Authors and Affiliations

  • Peter A. Newman
    • 1
  • Sung-Jae Lee
    • 2
  • Ellen T. Rudy
    • 3
  • Allison Diamant
    • 4
  • Naihua Duan
    • 5
  • Terry Nakazano
    • 6
  • William E. Cunningham
    • 7
  1. 1.Factor-Inwentash Faculty of Social WorkUniversity of TorontoTorontoCanada
  2. 2.Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute, Center for Community HealthUniversity of CaliforniaLos AngelesUSA
  3. 3.Los Angeles County Department of Health ServicesSexually Transmitted Disease ProgramLos AngelesUSA
  4. 4.Ronald Reagan UCLA Medical CenterUniversity of CaliforniaLos AngelesUSA
  5. 5.Department of PsychiatryColumbia University Medical CenterNew YorkUSA
  6. 6.Division of General Internal Medicine & Health Services Research, UCLA David Geffen School of MedicineUniversity of CaliforniaLos AngelesUSA
  7. 7.Department of Health Policy and Management, UCLA Fielding School of Public HealthUniversity of CaliforniaLos AngelesUSA

Personalised recommendations